The Series C funding will support the clinical advancement of Vega Therapeutics’...
The Nordics are a well-known powerhouse of pharmaceutical innovation and product...
A new set of European Society of Cardiology (ESC) guidelines was shared at the 2...
In this 2023 study, Sjoland and other researchers found an elevated excess risk ...
Up to 45% of the trial costs for the dose-determining Phase 1b trial will be fun...
Cipla Medpro South Africa has signed a binding term sheet to acquire Actor Pharm...
The UK MHRA has granted marketing authorisation for AbbVie’s Aquipta (atogepant)...
The Chinese NMPA approved for AstraZeneca’s Calquence to treat chronic lymphocyt...
Nestlé has sold its peanut allergy drug Palforzia to Swiss biopharma Stallergene...
Digital information exchange can be safer, cheaper and more environmentally frie...
In the latest edition of STAT's Health Tech newsletter: Biofourmis turmoil, Alex...
WEST LAFAYETTE, Ind. – A new cancer therapy developed by Purdue University resea...
IOP Publishing (IOPP) has appointed Dr. David Gevaux as the first Chief Editor o...
The severe global threat posed by invasive alien species is underappreciated, un...
In a review published in Engineering, scientists explore the burgeoning field of...
Around 5.2% of the global population carries abnormal hemoglobin genes [1]. Each...
